NCT00526461 2023-08-04
Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed
Clinical Trials
14 trialsNCT00470496 2022-07-25
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT03090412 2022-06-02
Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer
Roswell Park Cancer Institute
Phase 2 Terminated
NCT03757754 2018-11-29
HPPH
Zhejiang Hisun Pharmaceutical Co. Ltd.
Phase 1 Unknown
NCT01140178 2018-10-16
A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx
Roswell Park Cancer Institute
Phase 1 Completed
NCT02119728 2016-04-21
Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity
Roswell Park Cancer Institute
Phase 2 Withdrawn
NCT00670397 2016-03-16
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer
Roswell Park Cancer Institute
Phase 1 Terminated
NCT01238042 2014-12-02
Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus
Roswell Park Cancer Institute
Phase 1 Completed
NCT01236443 2014-01-13
Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
Roswell Park Cancer Institute
Phase 1 Completed
NCT00281736 2014-01-03
Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT01035437 2012-07-02
Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer
Roswell Park Cancer Institute
Phase NA Withdrawn
NCT00060268 2011-03-09
Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
Roswell Park Cancer Institute
Phase 1/2 Completed
NCT00017485 2011-03-07
Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT00025571 2011-03-07
Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed